Domino Company Spotlight
Domino Company Spotlight
Domino Integrated Solutions Group
The Integrated Solutions Group of Domino Printing Sciences Plc is a leading innovator of technologies and full solutions that provide robust traceability and product security systems. Domino offers a full integration service that extends from initial needs-based consultation, technology evaluation and testing through to full system implementation. By integrating the leading AIDC (automatic identification and data capture) technologies available and combining these with a data management platform that extends from control over data flows within the enterprise, to transfer to external parties, the company offers an extensive range of modular and scalable track & trace systems. Configurable RFID packages are available that can provide immediate cost benefit and enable customers to avoid unnecessary costs associated with RFID implementation programmes.
Domino offers a range of solutions specific to the pharmaceutical market. Its specialists are trained to understand the needs of the pharmaceutical industry and identify the coding and traceability solutions required for each customer within the supply chain. Both ink jet and laser products can be supplied with validation packs for GAMP and 21-CFR part 11 compliance. Domino's technology and integrated solutions are utilised by major manufacturers for product traceability and anti-counterfeiting measures in applications that include the laser scribing of tablet cartons and blister packs and the direct marking of individual tablets and capsules. In addition, its integrated solutions can be deployed across the entire supply chain to ensure item level identification from original product manufacture right through to delivery to the individual patient.
Contact Details
New Insights Into T Cell Exhaustion and Inflammation in Long COVID
April 17th 2025Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and evidence of T cell exhaustion in long COVID patients, providing deeper insight into post-infection immune disruption.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
